News related to
much

Arabian Post Staff -Dubai US emergency crude holdings have fallen below 300 million barrels for the first time in more than four decades as Washington continues drawing oil from the Strategic Petroleum Reserve to cushion energy markets from Middle East supply disruptions. Stocks in the Strategic Petroleum Reserve dropped by about 5.3 million barrels during the week ended August 14 to 293.4 million barrels. That was the […]

The US Strategic Petroleum Reserve has fallen below 300 million barrels, deepening concerns over Washington’s emergency oil cushion as prolonged Middle East supply disruptions force further withdrawals from government stockpiles. Federal inventory data for the week ended August 7 put the reserve at about 298.7 million barrels after a weekly draw of roughly 6.1 million barrels. That was the lowest level since 1983 and extended a sharp […]

By Ashok Nilakantan Ayers For much of independent India’s history, the security response to communal violence and terrorism was essentially reactive: an attack occurred, intelligence agencies investigated it, police made arrests, and security forces moved in after violence had already begun. Over the past five years, however, India’s counter-terrorism architecture has been moving towards a […]

The article From reaction to prevention: India’s five-year turn against radicalisation appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

Malaysia’s palm oil research agency is advancing a bio-based immersion coolant for data centres as the country searches for ways to curb the heavy water and electricity demands created by its fast-growing artificial intelligence infrastructure.

The Malaysian Palm Oil Board has developed Sawit EcoTherm, a non-conductive dielectric fluid made largely from palm-derived materials that allows servers and other computing components to be immersed directly in coolant. The technology eliminates the need for conventional evaporative cooling towers and is being positioned for AI and hyperscale facilities where rising processor densities are producing substantially more heat.

Sawit EcoTherm remains at the pre-commercial stage, with pilot projects, technical validation and partnerships with data centre operators among the steps required before widespread deployment. Researchers say the fluid could reduce cooling-related energy consumption by about 30% to 50%, largely by removing server fans and transferring heat directly from electronic components.

MPOB estimates that conventional water-based cooling across Malaysia’s expanding data centre industry could eventually require as much as 876 million litres of water a day. Other projections based on currently identified developments are lower, illustrating the uncertainty surrounding future capacity and cooling configurations. Data centres planned across Selangor, Johor and Negeri Sembilan have been estimated to require more than 445 million litres daily if projected demand materialises.

The pressure is particularly acute in Johor, which has become one of Asia’s fastest-growing data centre clusters because of its proximity to Singapore, available industrial land and established power and connectivity infrastructure. Water availability and grid capacity have increasingly become constraints as developers seek to commission large AI facilities.

Malaysia’s data centre and cloud computing investment approvals reached RM144.4 billion between 2021 and the middle of 2025. Global technology and infrastructure groups including Microsoft, Amazon, Google, ByteDance, Equinix and AirTrunk have committed billions of dollars to expanding computing capacity in the country.

AirTrunk announced plans this year to invest about $3 billion in two additional hyperscale campuses in Johor, adding more than 280 megawatts of capacity. Equinix separately unveiled an investment exceeding $190 million for another Kuala Lumpur facility designed to support more than 2,200 cabinets and equipped for advanced liquid cooling.

Those developments are accelerating interest in alternatives to traditional air and water cooling. AI servers can generate several times more heat than conventional computing equipment, making direct liquid cooling and immersion systems increasingly attractive as rack power densities rise.

Sawit EcoTherm uses palm-derived ester formulations engineered to provide electrical insulation while absorbing heat from processors, memory, power supplies and graphics processing units. MPOB has developed two formulations, EcoTherm 5s and EcoTherm 8s, both with dielectric breakdown strength exceeding 75 kilovolts.

The fluids are designed for single-phase immersion systems, where coolant remains liquid while circulating through a closed loop. The 8s formulation has a minimum flash point of 200 degrees Celsius, while the 5s version has a minimum of 160 degrees. Their characteristics are intended to combine thermal performance with relatively low pumping requirements.

Palm-derived material can also offer a cost advantage. Commercial synthetic and petroleum-based immersion fluids can cost about RM50 to RM80 per kilogram, while the raw-material cost for producing the palm formulation has been estimated at roughly RM20 to RM25 per kilogram. Final commercial pricing has not been announced.

MPOB says up to 95% of the material used in Sawit EcoTherm can come from renewable bio-based sources. The formulations are biodegradable and free from PFAS, a class of persistent chemicals that has attracted growing regulatory scrutiny because of its resistance to environmental degradation.

The technology nevertheless carries broader sustainability questions because expansion of oil-palm cultivation has historically been associated with deforestation, biodiversity loss and pressure on wildlife habitats. The environmental case for palm-based coolant will therefore depend partly on traceable sourcing, lifecycle emissions and whether demand can be met without encouraging additional land conversion.

Immersion cooling itself is not new. Vegetable-derived, mineral-oil and synthetic dielectric fluids are already available, while many operators developing AI facilities favour direct-to-chip liquid cooling because it can be integrated into server architectures without fully submerging equipment. Commercial success for Sawit EcoTherm will depend on compatibility with hardware, long-term fluid stability, maintenance requirements and acceptance by server manufacturers.

A new benchmark of handwritten medical prescriptions shows that compact modern optical character recognition systems can decipher doctors’ handwriting far better than established OCR engines, while remaining well short of the accuracy needed for autonomous clinical use. The April 2026 test compared PP-OCRv5, GLM-OCR, Tesseract and EasyOCR on cropped handwritten prescription words. GLM-OCR produced the best character-level performance, recording a Character Error Rate, or CER, of 0.328. […]

VinFast is joining forces with Gowa Motor Group to create a venture aimed at accelerating the electric vehicle maker’s retail expansion across Indonesia, with plans for at least 30 new showrooms and service centres. The agreement strengthens VinFast’s push to build a nationwide sales and aftersales ecosystem alongside its growing manufacturing presence. The memorandum of understanding envisages the two companies establishing a joint venture that will develop […]

Arabian Post Staff -Dubai ADQ has proposed buying all remaining shares in AD Ports Group for cash, potentially giving Abu Dhabi’s sovereign investment structure full ownership of one of the emirate’s most important ports, shipping and logistics businesses. The Abu Dhabi investment company, whose assets and investments were brought under the umbrella of sovereign investment platform L’IMAD earlier this year, holds about 75.42% of AD Ports Group. […]

Advertisements

Arabian Post Staff -Dubai IntrospeXion is expanding psychological support for workers in demanding UAE operating environments, deepening its engagement with offshore and onshore teams as companies place greater emphasis on mental wellbeing, resilience and human performance. The specialist workplace mental health consultancy has been working with Blu Subsea Diving Services, a Dubai-headquartered subsea services company, providing support to employees exposed to the pressures associated with offshore, marine […]

President Donald Trump has ordered the Pentagon to substantially scale back joint military exercises with South Korea, linking the decision to his relationship with North Korean leader Kim Jong Un and Seoul’s refusal to support Washington’s military campaign against Iran. Trump announced the move hours before the annual Ulchi Freedom Shield exercise was due to begin on Monday, August 17. The drills nevertheless started as scheduled, with […]

Special Event for F2P Game Developers Launches Alongside the Announcement

SINGAPORE- Media OutReach Newswire – 17 August 2026 – With the global game market grown to an approximate value of US$200 billion annually, JUNEiNTER unveils a model designed to estimate the future revenue of individual games.

JUNEiNTER announced the release of the “LCP Model,” which estimates future revenue based on operating data from live service games and a public event of a free-trial marking its launch.

Whereas games generate recurring monthly cash flows and function as digital assets, the industry has lacked established standards to calculate the future revenue of individual titles — making their revenue streams difficult to be utilized as measurable financial assets.

The LCP Model was developed from the fundamental question: “How much revenue will our game generate?” The S66 Engine, which applies the LCP Model, analyzes actual service data accumulated from launch to calculate potential future revenue. Accordingly, it has been simulated about 90,000 times, confirming its consistency and reproducibility.

To mark the unveiling of the LCP Model, JUNEiNTER is holding a public event for developers to get revenue estimations for their own games. Eligible participants are games that use the F2P model monetized through in-app purchases (IAP) or combining in-app purchases with in-app advertising. Steam and console games are excluded.

Participating developers will also be offered additional special benefits for future usage. Eligibility requirements and details of the benefits are available on JUNEiNTER’s official website (https://gv.juneinter.com).

A JUNEiNTER spokesperson said, “Revenue estimates generated by the S66 Engine are not intended to be investment solicitation, fundraising, or a guarantee of returns. The results are estimates based on the data submitted by developers and the model’s criteria, and may differ from actual revenue.”

Media Contact
Teresa Lee / Business Operations Team / [email protected] / +82-10-2144-4979 /
Hashtag: #LCPmodel #S66 #JUNEinTER #gamerevenueestimation #mobilegaming #gamedevelopers #B2B #F2P #gamevaluation #live-service #gaming

The issuer is solely responsible for the content of this announcement.

JUNEiNTER Co., Ltd

Founded in 2002, JUNEiNTER Co., Ltd. is a South Korean game company that has developed, serviced, and published online and mobile games, best known for publishing GetAmped (PC) and My Oasis (mobile). The company has expanded its lineup through in-house development, co-development, and investment over the years.

Arabian Post Staff -Dubai Iran has resumed crude loading at Kharg Island’s western terminal after a 25-day interruption, signalling a cautious restart at its main oil-export hub while Tehran expands alternative maritime and land-linked routes to reduce its exposure to the Strait of Hormuz blockade. Satellite imagery showed a very large crude carrier, or VLCC, berthed at the western terminal on August 12, the first vessel there […]

China’s artificial intelligence race has intensified with Z. ai unveiling a coding model with powerful cybersecurity capabilities and DeepSeek pushing an upgraded flagship into wider commercial use, reinforcing the country’s growing challenge to leading US developers. Z. ai’s GLM-5.3 has emerged as the more striking of the two launches because of its ability to identify software vulnerabilities. The company said the model scored 84.5 per cent on […]

Arjavi Indraneesh China’s carefully constructed Gulf strategy is facing one of its toughest tests as Iran’s confrontation with the United States disrupts energy flows, threatens Arab partners and exposes the limits of Beijing’s influence over Tehran. The immediate pressure point is the Strait of Hormuz, where shipping traffic remains sharply below normal levels after months […]

The article Iran escalation puts China’s Gulf strategy under serious strain appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

Washington is preparing another escalation of economic pressure on Iran, with Treasury Secretary Scott Bessent promising measures without precedent even as the options left to exploit carry growing risks for energy markets, China relations and the US economy. Bessent has said new steps will be announced next week and described the strategy as combining extreme financial isolation with the continuing blockade of Iranian ports. The administration has […]

Russia’s second domestically built ice-class LNG carrier has begun its first Arctic voyage, strengthening Moscow’s capacity to move liquefied natural gas despite Western sanctions and a shortage of specialised vessels. The Konstantin Posiet departed Bolshoy Kamen Bay in Primorsky Krai and headed towards the Northern Sea Route, the Arctic shipping corridor running along Russia’s northern coastline. Shipping data indicated that the vessel was due to reach an […]

Firebird has opened a large-scale artificial intelligence computing facility in Armenia, launching an ambitious expansion that is expected to deploy more than 70,000 NVIDIA Blackwell and Rubin GPUs by the end of 2027. The facility at Hrazdan marks the operational debut of Firebird’s international AI infrastructure platform. The company plans to expand the Armenia operation to 300 megawatts of computing capacity through a three-phase programme, potentially establishing […]

The global race to develop new medicines is entering a new phase, and the UAE is positioning itself as one of the regions investing heavily in that transformation.  Biotechnology companies, artificial intelligence researchers, healthcare providers, and government institutions are increasingly working together to accelerate drug discovery, improve clinical research, and reduce the time it takes for promising treatments to reach patients. For decades, medicine development has been […]

HONG KONG SAR – Media OutReach Newswire – 13 August 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 2Q2026 and provides full year outlook update.

2Q26 Business and Financial Highlights

  • Bora delivered historically record-high quarterly revenues of NT$5,889 million in 2Q26, up 47.2% quarter-over-quarter driven by broad-based operational momentum, with basic EPS of NT$4.36.
  • CDMO revenue growth and increased site utilization rates, along with strong growth in the rare disease business and a return to growth for generics business of the Pharma Sales operations lifted group profitability, with gross margin expanding to 41.3% from 36.0% and operating margin reaching 16.8% from 10.2% in 1Q26. Excluding one-time costs related to the Weider Global Nutrition transaction, operating margin was approximately 18%.
  • CDMO’s strong backlog of US$317 million as of end of 2Q26, another historical high following a strong quarter, signals that Bora’s core business continued to perform with higher demand.
  • Pharma Sales’ rare disease franchise continues to show double digit sequential growth and the increased demand from government channels during the quarter with stabilized pricing in DLS has lifted the generics business back to normal.
  • Reflecting Bora’s recent increase in investment in Sunway Biotech, from 35.97% to 42.27% and subsequent acquisitions of Weider Global Nutrition’s, the Company has introduced “Consumer Healthcare (CHC)” as a new segment in its revenue mix disclosure beginning this quarter. In 2Q26, revenues from CHC were NT$824.76 million in 2Q26, a 354.4% increase QoQ and 234.3% YoY, and contributed to 14% of the Bora Groups consolidated revenues, an all-time high.
  • Cash-on-hand reached an all-time high of NT$8,431 million as the Company was preparing for MacroGenics Inc.’s Rockville facility acquisition.
  • The Company has kicked off a group-wide AI in Manufacturing, BORA AIM, program aimed at improving process efficiency across sites, spanning engineering, quality and production. Bora has also signed a partnership with Insilico Medicine for AI drug discovery. The first 6 months will focus on beta version testing of the Bora AIM agents and AI champions to drive process consolidation.
  • Share capital increased 0.3% during the quarter from employee stock option exercise.


Mr. Bobby Sheng, Chairman of Bora Group, stated, “We are pleased to announce Bora Group’s return to strong operating profits and double to triple-digit growth on all key margins sequentially, as well as demonstrate that our soft 1Q26 performance was anomalous rather than structural. Our impressive sequential improvement was driven entirely by strong demand from both our CDMO and Pharma Sales businesses, with 2Q26 manufactured batches reaching 0.38 billion doses, led by increased commercial production in Maple Grove and Zhunan sites and a full quarter of operations in the Maryland injectable facility, while our flagship products DLS and VIGAFYDE® in Pharma Sales continues to secure leading market share.

Our focus right now is execution. CAPEX investments in our mature sites, including facilities in Taiwan and in Canada, continue to deliver operational leverage driven by gross margin expansion, and our recently acquired oral solid dose facility in Maple Grove continues to show stellar and impactful demand as we sign more projects. Our 12-month rolling backlog is at historic high in almost all our sites, despite projected manufacturing delays at our Maryland injectable facility as we diligently respond to FDA audit observations from a recent audit. Bora Group’s commitment to the fast-growing Biologics manufacturing industry took another big step as we look to integrate 12,000 liters of capacity, and 3 commercial products from our Rockville facility, as well as see revenue recognition from this acquisition starting Q3. As Bora’s CDMO footprint expands in the US, we continue to capture durable, high-value demand as customers increasingly prioritize supply security and onshore capacity.

In addition, we are seeing sustained growth and improved gross margins in the Vigabatrin franchise, our most important, rare disease franchise, thanks to renegotiations with our partner vendors. Accelerated state and government orders for generics products increased 2Q26 revenues and 6 new generics launches have also supported a more diversified generics portfolio. Together, the advancement in rare disease franchise and generics business has positioned Bora’s Pharma Sales business, operating under the name Upsher-Smith, in a far stronger state than it was just a quarter ago.

As announced in July, we are excited to be developing a group-wide AI in Manufacturing program, BORA AIM, aimed at improving process efficiency across sites, spanning engineering, quality and production. We also announced a partnership with Insilico Medicine to enhance our understanding of AI drug discovery and create more customized AI manufacturing platforms for AIDD small molecules. In the next 12 months, Bora Group will be ready to showcase some exciting AI-enabled CDMO platforms that will truly add value to our partners and sharpen the overall competitive advantages of Bora Group.

As our momentum carries Bora into the second half of the year, we expect margins of our flagship products in Pharma Sales and CHC businesses to hold steady on continuous revenue growth, and improved efficiencies in the CDMO business in addition to consolidation of new revenues from the Rockville facility.”

2Q26 Operational Achievements & 2026 Outlook


Global CDMO Operations

Revenues increased 30.3% year-over-year and 29.0% quarter-over-quarter including internal orders, and 33.0% and 40.2% external orders only, or NT$2,116.4 million. The growth was primarily driven by a strong rebound in injectables following the semi-annual maintenance in 1Q26 and same period last year, and demand acceleration overall as we continue to meet the increasing backlog.

CDMO business also signed a record high US$378.2 million in total external wins. Highlighted by a 10+2-year, multi product commercial contract in our Maple Grove facility with a new top-20 pharma company, and 14 new molecules from pre-commercial programs from multiple new customers. Bora is confident in its mid- to long-term growth trajectory as pharma and biotech companies continue to look for US based CDMOs as a part of their efforts to onshore US production and improve supply chain resilience.

During the quarter, 0.38 billion doses, or 109 molecules, were developed and manufactured. Contribution from the top 20 global pharmaceutical companies stood at roughly 30% and should increase drastically in the next 8 quarters.

Looking at 3Q26, the Company is highly optimistic, with our backlog having climbed to an unprecedented level even after a strong quarter of manufacturing output. We do anticipate some timing shifts in revenue recognition related to scheduled semi-annual maintenance at our Maryland injectable site, alongside targeted quality-enhancement activities in connection with observations on passive RABS (Restricted Access Barrier System) line received from an FDA audit that took place 2Q26. However, there has been no reduction in total commercial batch productions in 2026 as we speak and several existing clients have initiated transfers to the FlexPro isolator filling lines. RFP activity has risen, with the first GMP PPQ campaign starting in August. On the newest, isolator-based AST lines, factory acceptance testing (FAT) is planned for Q326, with qualification to follow in 2027, expanding our ability to onboard small-scale isolator programs, including tech transfers.

On biologics, Rockville facility revenue recognition started in the first month of 3Q26 and the site has confirmed that it is on track to deliver batch production volumes ahead of last year’s run rate of around 13 batches for the remainder of 2026. We anticipate one-time transaction costs from this acquisition of approximately 3% of the purchase price including legal and FA fee and transition related expenses as stated in the Transition Service Agreement. The Rockville acquisition expands biologics capacity and brings integrated drug substance (DS) and drug product (DP) capabilities under one roof, strengthening our end-to-end service offering and attracting more inbound opportunities and higher value conversion with cross selling opportunities for our injectable business.

For our strategic investment in Tanvex Biopharma, the main Bora Biologics platform company, although the business still operates at a loss, Tanvex has built a strong presence in international conferences, especially Bio International in the US in June. We have seen a positive uptick in pipeline from leading biotechs and heavy weight biopharmas, and stable demand for early-stage PD programs in Zhubei. The Rockville acquisition is expected to orchestrate and accelerate opportunities for Tanvex in the coming quarters.

Pharma Sales Operations

Revenues decreased 2.7% year-over-year and increased 30.4% quarter-over-quarter, arriving at NT$2,934.04 million in 2Q26. The year-over-year decrease was mainly due to a product rationalization program in 2025 that lead to the withdrawal of a basket of legacy generics products.

During the quarter, specialty and brand came in strongly, up 58.8% for the quarter QoQ and displayed almost 50% growth against 2025 run rate. The rare-disease Vigabatrin franchise demand is robust, and our continuous investment in the segment has resulted in much broader patient access compared to when we acquired Upsher-Smith 28 months ago. On coverage, we are on track to achieve year-end formulary goal of >50%, supported by more regional plans and strong physician adoption as they gain experience with VIGAFYDE®. The Company has also renegotiated contracts with suppliers, leading to improved gross margins for the franchise during the quarter and expects full economic contribution starting 3Q26. Simultaneously, the Company out-licensed its non-core assets, Stiripentol generics and 505(b)(2), during the quarter, fully capturing the economic value of these drug assets to enable fueled and renewed focus on core specialty and brand business.

The generics business returned to stability as Upsher-Smith successfully defended flagship product DLS. High value generics advanced 20.6% sequentially from downstream restocking, narrowing the year-to-date YoY decline against 2025 run rate to high teens.

Having executed our way through specialty and brand business growth and generics portfolio optimization, we have returned to the 2023–2024 peaks of Pharma Sales performance but with healthier and more resilient operating profits. As of now, Upsher-Smith sees 6 ANDA pending approval.

CHC Operations

Bora Group has increased holdings of Sunway Biotech to 42.27% through a private placement at $NT 596 million. Subsequently, Sunway completed the acquisition of Weider Global Nutrition (WGN), a global nutritional supplements company with offices in the US, Spain, and Germany and products sold in over 60 countries. Benefitting from the consolidation of WGN that started in May, Consumer Health business totaled NT$824.76 million in 2Q26, a 354.4% increase QoQ and 234.3% YoY. Focusing on longevity and sports nutrition, WGN’s distribution strength is expected to meaningfully contribute to the CHC business in 2026 and beyond and shall deliver vertical-integration synergies to Sunway’s existing ingredients’ manufacturing operations. Together, the WGN acquisition is expected to catapult Sunway Biotech into a leading global nutritional supplements company and substantially accelerate top and bottom-line improvements in the future.

Recent Investor Conference

Bora will host English online earnings call at 8:00 a.m. Taiwan time on Aug. 14th, 2026. The event will cover the Company’s 2Q26 financial and business results and 2H26 outlook.

English Online Earnings Presentation Link: https://teams.microsoft.com/meet/225504163505748?p=UyyncWl1CnOzjBCNKD

Bora will participate in Goldman Sachs 2026 CDMO day in Singapore in Sept. For 1:1 meetings with management, please contact your GS representative.

Bora 2026 Earnings Schedule

Q3 2026: Expected in the 2nd week of Nov 2026
Q4 2026: Expected in the 2nd week of Mar 2027

Hashtag: #BoraGroup

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

For more, please visit:

Disclaimer:

This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

Minimal Company has unveiled its second-generation smartphone with an AMOLED display, 5G connectivity and significantly faster hardware, while retaining the physical QWERTY keyboard that distinguishes the device from mainstream touchscreen handsets. The Minimal Phone 2 marks a sharp change from the original model’s 4.3-inch E Ink screen. The new handset uses a 3.92-inch AMOLED panel with a 1080 by 1240 resolution and 90Hz refresh rate, giving users […]

Arabian Post Staff -Dubai Google has removed false information from its search results that declared OpenAI chief executive Sam Altman dead, after vandalism of public information sources fed incorrect data into one of the search engine’s prominent information panels. The error appeared on August 12, when searches for Altman displayed a death date of August 12, 2026. Screenshots of the result spread rapidly across X and Reddit […]

The UAE’s new restrictions on social media access for children under 15 could reach far beyond conventional social networks, drawing gaming, streaming, education, ecommerce and other digital services into a widening child-safety compliance regime. Cabinet Resolution No. 106 of 2026 sets 15 as the minimum age for maintaining a personal social media account. Children below that threshold cannot create, use or operate covered accounts or access features […]

Arabian Post Staff -Dubai Saudi Arabia has emerged among the world’s 10 leading destinations for private artificial intelligence investment, strengthening its position in a global race to secure capital, computing capacity and specialised talent. The World Development Report 2026, The Promise of Artificial Intelligence, places the Kingdom among a relatively small group of economies attracting substantial private investment into AI. The assessment comes as Riyadh directs more […]

Cloudflare recorded a sharp escalation in high-bandwidth distributed denial-of-service attacks during the second quarter of 2026, mitigating 805 network-layer attacks that exceeded 1 terabit per second as attackers increasingly deployed overwhelming bursts of traffic against online infrastructure. The figure was more than six times the 130 terabit-scale attacks recorded during the first quarter. It brought the total number of attacks exceeding 1 Tbps during the first half […]

Google has unveiled its Pixel 11 smartphone range with higher starting prices, a new Tensor G6 processor and deeper Gemini integration, placing artificial intelligence at the centre of its latest challenge to Apple and Samsung. The Pixel 11 starts at $899, while the Pixel 11 Pro is priced from $1,099 and the larger Pixel 11 Pro XL from $1,299. All three models are available for pre-order and […]

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA